MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic shares outstanding 1986–2027

Medtronic had 1,279,170,000 shares outstanding on 9 November 2026. Medtronic had 1.29B diluted shares on average over the last twelve months, up 0.0% on the twelve months before. In fiscal year 2026 the average was 1.29B.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM31 Jul 20261.29B+0.02%1.28B
FY202624 Apr 20261.29B-0.14%1.28B
FY202525 Apr 20251.29B-3.03%1.29B
FY202426 Apr 20241.33B-0.20%1.33B
FY202328 Apr 20231.33B-1.38%1.33B
FY202229 Apr 20221.35B-0.19%1.34B
FY202130 Apr 20211.35B+0.21%1.34B
FY202030 Apr 20201.35B-0.47%1.34B
FY201926 Apr 20191.36B-0.78%1.35B
FY201827 Apr 20181.37B-1.67%1.36B
FY201728 Apr 20171.39B-2.42%1.38B
FY201629 Apr 20161.43B+28.58%1.41B
FY201530 Apr 20151.11B+9.41%1.10B
FY201425 Apr 20141.01B-1.35%1.00B
FY201330 Apr 20131.03B-3.06%1.02B
FY201230 Apr 20121.06B-2.02%1.05B
FY201130 Apr 20111.08B-2.50%1.08B
FY201030 Apr 20101.11B-1.50%1.11B
FY200930 Apr 20091.13B-1.38%1.12B
FY200830 Apr 20081.14B-1.70%1.13B
FY200730 Apr 20071.16B-4.56%1.15B
FY200630 Apr 20061.22B-0.13%1.20B
FY200530 Apr 20051.22B-0.51%1.21B
FY200430 Apr 20041.23B-0.22%1.21B
FY200330 Apr 20031.23B+0.29%1.22B
FY200230 Apr 20021.22B-0.13%1.21B
FY200130 Apr 20011.23B+0.21%1.20B
FY200030 Apr 20001.22B+1.31%1.19B
FY199930 Apr 19991.21B+2.59%1.18B
FY199830 Apr 19981.18B+0.92%1.15B
FY199730 Apr 19971.17B+22.55%1.14B
FY199630 Apr 1996951.78M+3.24%951.78M
FY199530 Apr 1995921.92M+0.21%921.92M
FY199430 Apr 1994920.00M-2.03%918.46M
FY199330 Apr 1993939.05M-1.15%939.05M
FY199230 Apr 1992950.00M-0.30%950.00M
FY199130 Apr 1991952.86M+5.19%952.86M
FY199030 Apr 1990905.83M+2.30%905.83M
FY198930 Apr 1989885.46M+2.36%885.46M
FY198830 Apr 1988865.00M+5.49%865.00M
FY198730 Apr 1987820.00M-7.87%820.00M
FY198630 Apr 1986890.00M—890.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Medtronic's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.